Home » Schering-Plough Gets EU, US Approvals for IV Formulation of Temozolomide
Schering-Plough Gets EU, US Approvals for IV Formulation of Temozolomide
Schering-Plough Corp. announced that the European Commission and the US FDA both approved the intravenous or IV formulation of temozolomide as an alternative to the already approved oral form of the drug.
RTTNews
RTTNews
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May